- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02706340
Expulsion of Immediate Postplacental Copper Intrauterine Devices at Six Months: A Prospective Cohort Study (PPIUD)
November 13, 2018 updated by: University of Pennsylvania
Expulsion of Immediate Postplacental Copper Intrauterine Devices at Six Months: A Prospective Cohort Study (PPIUD)
This is an observational study enrolling women who have had a copper intrauterine device placed immediately after childbirth.
The study follows participants for 6 month in order to evaluate the primary outcome of IUD expulsion within 6 months of delivery.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The purpose of the study is to measure the rate of expulsion of the copper intrauterine device (ParaGard®) when placed immediately after childbirth.
Many women in the United States have unintended pregnancies.
Long-acting reversible birth control methods, like the copper intrauterine device (IUD), help prevent unintended pregnancy.
This is because, once in place, the copper IUD provides excellent pregnancy prevention, and women using it do not have to do anything extra to make sure it works (like taking a birth control pill every day, for example).
The copper IUD is safe and well liked among women who use it.
Around the world, women have been getting their IUD fitted right after childbirth for the past 20 years, and this practice has been shown to be safe.
This service has been offered at HUP since early 2014.
When the IUD is placed after birth, there is a chance that it could fall out, as the uterus shrinks back to its pre-pregnancy size.
Women who get their IUD fitted right after childbirth will be observed, and describe the rate of IUD expulsion at 6 months postpartum.
Factors associated with IUD expulsion will be noted.
Adult pregnant women delivering at the Hospital of the University of Pennsylvania, desiring an immediate IUD, and willing to follow up 6 months after birth, will be eligible to participate.
Study Type
Observational
Enrollment (Actual)
309
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19143
- Hospital of the University of Pennsylvania
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Adult pregnant women, at least 24 weeks' gestation, anticipating a delivery and desiring an immediate postplacental TCu380A IUD, and adult women who have had a delivery and received an immediate post placental TCu380A IUD.
Description
Inclusion Criteria:
- Adult woman age 18 years or more
- Pregnant, 24 weeks 0 days gestation or more OR who have had a delivery at 34 weeks 0 days gestation or more
- Anticipating a delivery at the Hospital of the University of Pennsylvania
- Desiring an immediate postplacental TCu380A IUD, OR who have given birth and received an immediate postplacental TCu380A IUD
- Able and willing to give consent in English
- Willing to follow up 6 months after delivery
Exclusion Criteria:
- Allergy or contraindication to TCu380A
- Known cervical cancer or carcinoma in situ
- History of undiagnosed abnormal vaginal bleeding prior to pregnancy
- Unwilling to follow up in the six months following delivery will be excluded
Additional exclusion criteria apply after delivery:
- Preterm delivery (33 weeks 6 days gestation or less at birth)
- Clinical diagnosis of chorioamnionitis or treatment for presumed chorioamnionitis
- No longer desiring immediate postplacental TCu380A placement
- Subjects aged less than 18 years
- Men are excluded by the nature of this women's health research.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Vaginal delivery
Women who have had a copper IUD placed within 10 minutes of a vaginal delivery of at least 34 weeks 0 days gestation.
|
|
Cesarean delivery
Women who have had a copper IUD placed within 10 minutes of a cesarean delivery of at least 34 weeks 0 days gestation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The primary objective is to measure the rate of expulsion of the copper intrauterine device (TCu380A, marketed as ParaGard®) when placed within 10 minutes of placental delivery among women delivering at the University of Pennsylvania.
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2015
Primary Completion (Actual)
July 1, 2018
Study Completion (Actual)
July 1, 2018
Study Registration Dates
First Submitted
January 26, 2016
First Submitted That Met QC Criteria
March 7, 2016
First Posted (Estimate)
March 11, 2016
Study Record Updates
Last Update Posted (Actual)
November 15, 2018
Last Update Submitted That Met QC Criteria
November 13, 2018
Last Verified
November 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- 822078
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postpartum
-
Women's College HospitalCanadian Institutes of Health Research (CIHR); Michael Garron HospitalCompletedPostpartum Depression | Postpartum Anxiety | Postpartum Blues | Postpartum Mood DisorderCanada
-
University Hospital, Clermont-FerrandUnknownPostpartum Depression | Postpartum Hemorrhage | Postpartum Women | Postpartum Stress | Postpartum AnxietyFrance
-
Assistance Publique Hopitaux De MarseilleUnknown
-
University of Colorado, DenverEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedPostpartumUnited States, Guatemala
-
The Jones InstituteUnknownPostpartum Depressive Mood | Postpartum Sexual FunctionUnited States
-
University of PittsburghAmerican Psychological Foundation; The Pittsburgh FoundationRecruitingPostpartum Depression | Pregnancy Related | Psychological Distress | Postpartum Sadness | Postpartum Anxiety | Postpartum BluesUnited States
-
Cairo UniversityRecruiting
-
London School of Hygiene and Tropical MedicineDepartment for International Development, United Kingdom; Economic and Social... and other collaboratorsCompleted
-
University of North Carolina, Chapel HillSociety of Family PlanningCompletedPostpartum ContraceptionUnited States
Clinical Trials on No intervention - observational study only
-
University Hospital, Basel, SwitzerlandCompletedPostoperative Complications | Intraoperative Complications | Patient Safety | Risk ManagementNew Zealand, Switzerland, United States, Netherlands, Spain, Austria, Turkey, United Kingdom, Australia, Greece, Ireland, Italy
-
University Medicine GreifswaldRecruitingLymphoma | Colorectal Cancer | Pancreas CancerGermany
-
Umeå UniversityCompletedBrain Injuries | Traumatic Intracranial HemorrhageSweden
-
Brian Hiestand MDEmergency Medicine FoundationCompletedHeart Failure, CongestiveUnited States
-
University Medicine GreifswaldRecruitingMalnutrition | Acute PancreatitisGermany
-
University Medicine GreifswaldCompletedGastric Cancer | Pancreatic Cancer | Small Intestine Cancer | Rectal Cancer | Neuroendocrine Tumors | Bile Duct Cancer | Colon Cancer | Liver Cancer | Oesophageal Cancer | GIST, MalignantGermany
-
Elliott Crouser MDCompleted
-
Groupe Hospitalier Paris Saint JosephCompleted
-
Ruijin HospitalHangzhou Genetron Medical Laboratory Co., Ltd.Recruiting
-
Audubon BioscienceEnrolling by invitationCardiovascular Diseases | Autoimmune Diseases | Infectious Disease | Pregnancy Related | Hematologic Malignancy | Oncology | Renal Disease | Gastro-Intestinal Disorder | Genitourinary DiseaseUnited States